Intravenous leiomyomatosis

Summary

Intravenous leiomyomatosis (MONDO:0003614) is a disease and 1 clinical trial. A subtype of leiomyomatosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 1

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	intravenous leiomyomatosis
Mondo ID	MONDO:0003614
DOID	DOID:5729
NCIT	C4518
SNOMED CT	254883003
UMLS	C0346200
MedGen	83417
Is cancer (heuristic)	no

Also known as: intravenous leiomyomatosis

Disease family

An umbrella term covering 1 Mondo subtype.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › musculoskeletal system benign neoplasm › benign muscle neoplasm › benign smooth muscle neoplasm › leiomyoma › leiomyomatosis › intravenous leiomyomatosis

Related subtypes (2): uterine corpus diffuse leiomyomatosis, disseminated peritoneal leiomyomatosis

Subtypes (1): uterus intravascular leiomyomatosis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 1.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	1

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06773819	Not specified	NOT_YET_RECRUITING	A Study on the Pathogenesis and Determinants of Intravenous Leiomyomatosis